Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
144M
-
Number of holders
-
60
-
Total 13F shares, excl. options
-
9.64M
-
Shares change
-
+4.65M
-
Total reported value, excl. options
-
$315M
-
Value change
-
+$155M
-
Number of buys
-
47
-
Number of sells
-
-16
-
Price
-
$32.69
Significant Holders of Applied Therapeutics, Inc. - COMMON STOCK (APLT) as of Q1 2020
68 filings reported holding APLT - Applied Therapeutics, Inc. - COMMON STOCK as of Q1 2020.
Applied Therapeutics, Inc. - COMMON STOCK (APLT) has 60 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.64M shares
of 144M outstanding shares and own 6.71% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (1.32M shares), FMR LLC (1.19M shares), Rock Springs Capital Management LP (846K shares), Knoll Capital Management, LP (642K shares), ALKEON CAPITAL MANAGEMENT LLC (638K shares), DRIEHAUS CAPITAL MANAGEMENT LLC (591K shares), VANGUARD GROUP INC (548K shares), BlackRock Inc. (531K shares), Point72 Asset Management, L.P. (529K shares), and FRANKLIN RESOURCES INC (340K shares).
This table shows the top 60 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.